ASCO 2020: head and neck cancer highlights

ASCO 2020: head and neck cancer highlights

Head and neck cancer at ASCO 2022Подробнее

Head and neck cancer at ASCO 2022

Head and neck cancer highlights at ASCO 2021Подробнее

Head and neck cancer highlights at ASCO 2021

ICAHO20 - ASCO Direct™ Highlights - Dr. Cristina Rodriguez - Head and Neck MalignanciesПодробнее

ICAHO20 - ASCO Direct™ Highlights - Dr. Cristina Rodriguez - Head and Neck Malignancies

ESMO 2020 Highlights on pembrolizumab in LA-HNSCC: The GORTEC 2015-01 “PembroRad” studyПодробнее

ESMO 2020 Highlights on pembrolizumab in LA-HNSCC: The GORTEC 2015-01 “PembroRad” study

ASCO 2020 Highlight: CẬP NHẬT UNG THƯ ĐẦU CỔ- BS. Jessica Bauman.Подробнее

ASCO 2020 Highlight: CẬP NHẬT UNG THƯ ĐẦU CỔ- BS. Jessica Bauman.

ASCO DIRECT HIGHLIGHT 2020 Riyadh [DAY1]Подробнее

ASCO DIRECT HIGHLIGHT 2020 Riyadh [DAY1]

ASCO 2020: highlights in immuno-oncologyПодробнее

ASCO 2020: highlights in immuno-oncology

Highlights from ASCO 2020Подробнее

Highlights from ASCO 2020

Mark Pegram, MD | Invite to San Francisco ASCO Virtual Direct HighlightsПодробнее

Mark Pegram, MD | Invite to San Francisco ASCO Virtual Direct Highlights

2020 West Oncology Conference HighlightsПодробнее

2020 West Oncology Conference Highlights

ASCO 2016 – Treating Head and Neck Cancer – Promising Early Data for the Oral Inhibitor BuparlisibПодробнее

ASCO 2016 – Treating Head and Neck Cancer – Promising Early Data for the Oral Inhibitor Buparlisib